SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus

Aventus ($AVT.X) is trending as community members highlight its low market cap and potential for a breakout, with some comparing it to other trending tokens. Recent company updates on LinkedIn, particularly partnerships and the appchain model, are generating discussion, as are technical analyses suggesting bullish patterns. Some traders are expressing frustration with $AVT.X's inability to hold gains.

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is trending as community members highlight its strong chart setup, accumulation patterns, and potential for a breakout. The focus is on bullish technical indicators and growing momentum, with some suggesting it could be the next big community-driven crypto run. Overall, the community sentiment points towards anticipation for a significant upward move.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Conversations around DJT are currently focused on political division and the recent death of Charlie Kirk, with community members expressing strong opinions and engaging in heated debates. Some users are pointing fingers and assigning blame, while others are calling for unity and an end to political violence. The stock appears to be heavily influenced by broader socio-political narratives.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is surging, sparking excitement among its community who are eyeing potential gains and referencing a possible DOJE ETF. Discussions revolve around holding strategies, potential price targets, and whether this rally has enough momentum to reach previous highs. Some community members are suggesting that it is on track to reach $1 soon.

Ainalyzr is a versatile and engaging platform designed to provide crypto traders with advanced tools and a fun, interactive environment. Powered by the Ainalyzr token, it offers real-time analysis of Solana-based tokens, gamified trading tools, and a space for users to explore market trends and make data-driven decisions. Ainalyzr merges functionality and entertainment, appealing to both seasoned and novice traders.

AInalyzr

AInalyzr ($AINAL.X) is gaining attention as community members anticipate a potential breakout, citing bullish chart patterns and encouraging others to "stack" before it's too late. The crypto is being touted as a hidden gem with "rocket" potential, with many emphasizing the opportunity to get in early. Conversations suggest a strong sense of conviction among those already invested.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crypto "crow with knife" ($CAW.X) is trending, driven by community enthusiasm and its growing presence as a meme coin, particularly within the Cronos ($CRO.X) ecosystem.  Active discussions revolve around its unique branding and potential, with supporters emphasizing its community-driven nature and multichain functionality across $SOL.X, $CRO.X, and $ETH.X.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as community members highlight its charitable donations to dog shelters, with many expressing excitement about the project's potential and comparing it to other meme coins. The community is actively discussing the coin's mission and anticipating further gains, viewing it as a 'dog-coin' with a cause. There is also increased interest around 'what is UpDog?'

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community rallies around a potential breakout, fueled by bullish chart patterns and significant accumulation by key players. Many are pointing to $AINAL.X as the next big opportunity within the Solana ecosystem, urging others to get in early before a potential surge. The overall sentiment suggests strong momentum and anticipation for further gains in the near future.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is trending as community members discuss its potential for growth and utility compared to Bitcoin, particularly highlighting faster transaction times and lower fees. Some analysts anticipate a breakout, while others point to accumulation patterns and potential ETF catalysts. Discussions include price targets and whether it can outperform Bitcoin as market focus shifts from speculation to utility.

Trump For President

Conversation around TRUMP.X seems to be driven by speculation around an upcoming meme coin launch and its potential impact, with some users drawing comparisons to previous Trump-related coins. There is also discussion around political implications and events, with community members expressing strong opinions. The community appears to be weighing potential gains against the inherent risks associated with politically themed meme coins.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New Strong Sell Stocks for August 22nd

INKT, MNR and CSIQ have been added to the Zacks Rank #5 (Strong Sell) List on August 22, 2025.

MiNK Therapeutics stock falls after William Blair downgrade

Investing.com -- MiNK Therapeutics (NASDAQ:INKT) stock fell 30% on Monday, paring a massive 730% gain from Friday after William Blair downgraded the shares following the spectacular rally.

Shares of MiNK Therapeutics, Inc. (INKT) skyrocketed on Friday following the publication of a case from its clinical trial describing a complete and durable remission in a patient with metastatic, treatment-refractory testicular cancer following treatment with its cell therapy.<a href="https://stocktwits.com/symbol/INKT">INKT shares</a> were up about 466% at the time of writing.The patient had progressed after multiple lines of therapy, including platinum-based chemotherapy, autologous stem cell transplant, and multiple immune checkpoint inhibitors.However, they had complete clinical, radiologic, and biochemical remission, with no evidence of disease over two years later, after receiving a single infusion of agenT-797 alongside the cancer drug nivolumab.AgenT-797 is an off-the-shelf, cryopreserved invariant natural killer T (iNKT) cell therapy. It utilizes iNKT cells, which contribute to anti-tumor effects, from a healthy donor to treat a recipient.Donor iNKT cells were detectable up to six months post-infusion in the patient, and treatment was well-tolerated with no cytokine release syndrome (CRS) or graft-versus-host disease (GVHD).“These findings are part of a growing body of clinical evidence supporting the potential of agenT-797 in solid tumors,” the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://investor.minktherapeutics.com/news-releases/news-release-details/mink-therapeutics-announces-publication-complete-remission">said</a>.AgenT-797 is currently in clinical development for graft-versus-host disease (GvHD), solid tumors, and severe pulmonary inflammation. The company said that its ongoing mid-stage trial in gastric cancer is actively enrolling, with data readouts expected in the coming months.On Stocktwits, retail sentiment around INKT jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume jumped from ‘normal’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:1364/130;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_11_at_9_59_40_AM_png_9597d54c42.webp" alt="INKT's Sentiment Meter and Message Volume as of 10 a.m. ET on July 11, 2025 | Source: Stocktwits" width="1364" height="130"><figcaption>INKT's Sentiment Meter and Message Volume as of 10 a.m. ET on July 11, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that the company would have a share offering in the evening as it “absolutely” needs more money.<stembedurl>https://stocktwits.com/pow7904/message/620632189</stembedurl>MiNK ended the first quarter with a cash balance of $3.2 million.INKT stock is up by about 519% this year and by about 345% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/levi-stock-surges-after-analysts-raise-price-target-on-stock-retail-sentiment-extremely-bullish/ch8cXLQR5ZF">Levi Stock Surges After Analysts Raise Price Target On Stock, Retail Sentiment ‘Extremely Bullish’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

MiNK Therapeutics Stock Soars On Patient Receiving Full Remission In Testicular Cancer With Investigational Cell Therapy

“These findings are part of a growing body of clinical evidence supporting the potential of agenT-797 in solid tumors,” the company said.

Equity

Why MiNK Therapeutics Stock Is Up 11% Monday

MiNK Therapeutics shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placement financing of $5.8 million.
read more...

HC Wainwright Lowers MiNK Therapeutics (NASDAQ:INKT) Price Target to $9.00

MiNK Therapeutics (NASDAQ:INKT  Free Report) had its target price reduced by HC Wainwright from $10.00 to $9.00 in a report released on Thursday morning, Benzinga reports. They currently have...

Q4 2023 Mink Therapeutics Inc Earnings Call Transcript

MiNK Reports Fourth Quarter and Year-End 2023 Results

Launched and enrolling Phase 2 trial of allo-iNKTs with botensilimab/balstilimab and chemotherapy in second-line gastroesophageal cancers Announced collaboration with Immunoscape for development...

Earnings Outlook For MiNK Therapeutics

MiNK to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of...

MiNK Therapeutics announces preclinical data from MiNK-215

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.

INKT
MiNK Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INKT News

INKT MiNK Therapeutics Inc